Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma  Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,

Published byYolanda Alarcón Modified over 5 years ago

Similar presentations

Presentation on theme: "Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma  Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,"— Presentation transcript:

1 Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma 
Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi, MD, Koji Takami, MD, Masayuki Mano, MD, Shoji Kido, MD, Keiko Kuriyama, MD  The Annals of Thoracic Surgery  Volume 68, Issue 6, Pages (December 1999) DOI: /S (99)

2 Fig 1 Classification based on the extent of well differentiated bronchiolo-alveolar carcinoma (BAC) within the tumor tissue. (A) Type I, tumor has no BAC component (0%). (B) Type II, tumor less than 50% BAC. (C) Type III, more than 50% BAC. (D) Type IV 100% BAC. The right-upper corner shows a high-power magnification of each tumor tissue. The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3 Fig 2 (A) Postoperative overall survival among all the patients (n = 206). (B) Postoperative disease-free survival (DFS) among the patients undergoing potentially curative operation (n = 190). The groups with less of a BAC component showed a significantly worse prognosis (overall survival, p = ; DFS, p < ). The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4 Fig 3 (A) Postoperative overall survival among the patients with stage I disease (n = 151). (B) Postoperative disease-free survival (DFS) among the stage I patients undergoing potentially curative operation (n = 149). Type II patients showed a significantly worst prognosis (overall survival, p = ; DFS, p < ). In contrast, type I patients showed rather the same prognosis as type III patients. The Annals of Thoracic Surgery  , DOI: ( /S (99) )

Download ppt "Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma  Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,"

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Lung squamous cell carcinoma

Lung squamous cell carcinoma
Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,

Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,
A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.

A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.
Didier Lardinois, MD, Renate Rechsteiner, MD, R

Didier Lardinois, MD, Renate Rechsteiner, MD, R
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer  Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.

Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer  Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,

Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Similar presentations

Ads by Google